Related Experiment Video
Updated: Mar 30, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
p53/PUMA expression in human pulmonary fibroblasts mediates cell activation and migration in silicosis
Wei Wang1,2,3, Haijun Liu2,4, Xiaoniu Dai2
1Department of Respiratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
Abstract:
Phagocytosis of SiO2 into the lung causes an inflammatory cascade that results in fibroblast proliferation and migration, followed by fibrosis. Clinical evidence has indicated that the activation of alveolar macrophages by SiO2 produces rapid and sustained inflammation characterized by the generation of monocyte chemotactic protein 1, which, in turn, induces fibrosis. However, the details of events downstream of monocyte chemotactic protein 1 activity in pulmonary fibroblasts remain unclear. Here, to elucidate the role of p53 in fibrosis induced by silica, both the upstream molecular mechanisms and the functional effects on cell proliferation and migration were investigated. Experiments using primary cultured adult human pulmonary fibroblasts led to the following results: 1) SiO2 treatment resulted in a rapid and sustained increase in p53 and PUMA protein levels; 2) the MAPK and PI3K pathways were involved in the SiO2-induced alteration of p53 and PUMA expression; and 3) RNA interference targeting p53 and PUMA prevented the SiO2-induced increases in fibroblast activation and migration. Our study elucidated a link between SiO2-induced p53/PUMA expression in fibroblasts and cell migration, thereby providing novel insight into the potential use of p53/PUMA in the development of novel therapeutic strategies for silicosis treatment.
Insights
Silica (SiO2) exposure triggers lung inflammation and fibrosis by activating macrophages. This study reveals p53 and PUMA proteins are key mediators in silica-induced fibroblast activation and migration, offering potential therapeutic targets for silicosis.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Toxicology
Background:
- Silica (SiO2) inhalation causes lung inflammation and fibrosis.
- Activated macrophages release monocyte chemotactic protein 1 (MCP-1), inducing fibroblast proliferation and migration.
- The precise molecular mechanisms downstream of MCP-1 in pulmonary fibroblasts leading to fibrosis are not fully understood.
Purpose of the Study:
- To investigate the role of p53 in silica-induced pulmonary fibrosis.
- To elucidate the upstream molecular mechanisms regulating p53 expression.
- To determine the functional effects of p53 on fibroblast proliferation and migration.
Main Methods:
- Primary adult human pulmonary fibroblasts were cultured and treated with SiO2.
- Western blotting was used to assess protein levels of p53 and PUMA.
- Mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) pathways were investigated.
- RNA interference (RNAi) was employed to target p53 and PUMA.
Main Results:
- SiO2 treatment led to a significant and sustained increase in p53 and PUMA protein levels.
- MAPK and PI3K signaling pathways were implicated in SiO2-induced p53 and PUMA expression.
- Targeting p53 and PUMA via RNAi inhibited SiO2-induced fibroblast activation and migration.
Conclusions:
- A direct link exists between SiO2-induced p53/PUMA expression in pulmonary fibroblasts and enhanced cell migration.
- p53 and PUMA play critical roles in the fibrotic response to silica exposure.
- Targeting the p53/PUMA pathway presents a potential therapeutic strategy for treating silicosis.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules

